VolitionRx Ltd
VNRX
57 hedge funds and large institutions have $33M invested in VolitionRx Ltd in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 4 closing their positions.
600% more call options, than puts
Call options by funds: $56K | Put options by funds: $8K
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
229% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 7
27% more funds holding
Funds holding: 45 → 57 (+12)
12% more capital invested
Capital invested by funds: $29.3M → $33M (+$3.61M)
0.04% more ownership
Funds ownership: 0.78% → 0.82% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.19M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$759K |
| 3 |
LIM
Lagoda Investment Management
New York
|
+$541K |
| 4 |
Morgan Stanley
New York
|
+$430K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$381K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$378K |
| 2 |
VF
Virtu Financial
New York
|
-$173K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$57.7K |
| 4 |
Goldman Sachs
New York
|
-$46K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$20.8K |
VNRX Hedge Fund Activity: Q1 2021 in Review
57 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2021, worth a combined $33M — up 12% from $29.3M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new VNRX positions and 4 closed out — a net gain of 12 holders — while 23 added to existing stakes and 7 trimmed.
The largest buyer was Bridgeway Capital Management, adding an estimated $1.19M. The largest seller was GSA Capital Partners, cutting an estimated $378K.
- 57 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2021, up from 45 in Q4 2020.
- Funds reported $33M of VolitionRx Ltd stock for Q1 2021, up 12% quarter-over-quarter.
- 16 funds opened new VolitionRx Ltd positions in Q1 2021 and 4 closed out, a net change of +12 holders.
- The largest VolitionRx Ltd buyer in Q1 2021 was Bridgeway Capital Management, an estimated $1.19M added.
- The largest VolitionRx Ltd seller in Q1 2021 was GSA Capital Partners, an estimated $378K sold.
Based on aggregated 13F filings for Q1 2021.